AGBK vs JFR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AGBK presents a stark contradiction between fundamental valuation and market performance. While the Piotroski F-Score of 5/9 indicates stable financial health and the P/E (5.78) and PEG (0.18) ratios suggest significant undervaluation, the stock is in a severe technical downtrend with a -30.7% return across all major timeframes. The high Price-to-Book ratio (9.64) is an anomaly for a regional bank and suggests the market is skeptical of the book value or expects further equity erosion. Despite a 'Strong Buy' analyst consensus, the lack of growth and bearish price action warrant a neutral stance.
JFR exhibits a stable but fragile financial health profile with a Piotroski F-Score of 4/9 and no Altman Z-Score available. While the fund trades at a discount to book value (P/B 0.87) and below its Graham Number ($8.07), these value metrics are overshadowed by a catastrophic collapse in earnings growth (-52.80% YoY). Most critically, the dividend payout ratio of 300% indicates that the 12.56% yield is unsustainable and likely being funded by return of capital rather than earnings. Combined with a 0/100 technical trend and bearish insider activity, the outlook is negative.
Compare Another Pair
Related Comparisons
AGBK vs JFR: Head-to-Head Comparison
This page compares AGI Inc (AGBK) and Nuveen Floating Rate Income Fund (JFR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.